financetom
Business
financetom
/
Business
/
FirstCash's Q4 Adjusted Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
FirstCash's Q4 Adjusted Earnings, Revenue Rise
Jan 30, 2025 3:40 AM

06:28 AM EST, 01/30/2025 (MT Newswires) -- FirstCash ( FCFS ) reported Q4 adjusted earnings Thursday of $2.12 per diluted share, up from $2.04 a year earlier.

Analysts polled by FactSet expected $2.01.

Revenue for the quarter that ended Dec. 31 was $883.8 million, up from $852.1 million a year earlier.

Analysts surveyed by FactSet expected $897.7 million.

The company said its outlook for 2025 is "highly positive given the continued growth in pawn receivables and expectations for further pawn store additions and AFF merchant partner growth."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Royalty Pharma's Q1 Net Income, Revenue Falls
Royalty Pharma's Q1 Net Income, Revenue Falls
May 9, 2024
08:10 AM EDT, 05/09/2024 (MT Newswires) -- Royalty Pharma ( RPRX ) reported Thursday Q1 net income attributable to the company of $5 million, down from $341 million a year earlier. Analysts' estimates were not readily available for comparison. Total income and other revenue for the quarter ended March 31 were $568 million, down from $684 million a year earlier....
KKR Unit Announces Offer to Buy Alps Logistics at $37.05 Per Share
KKR Unit Announces Offer to Buy Alps Logistics at $37.05 Per Share
May 9, 2024
08:06 AM EDT, 05/09/2024 (MT Newswires) -- KKR & Co ( KKR ) unit Logisteed announced a tender offer for Alps Logistics at 5,774 Japanese yen ($37.05) per share. Price: 99.99, Change: +0.32, Percent Change: +0.32 ...
Oncolytics Biotech Receives German Regulatory Clearance to Evaluate Pelareorep with Modified Folfirinox in Pancreatic Cancer
Oncolytics Biotech Receives German Regulatory Clearance to Evaluate Pelareorep with Modified Folfirinox in Pancreatic Cancer
May 9, 2024
08:08 AM EDT, 05/09/2024 (MT Newswires) -- Oncolytics Biotech ( ONCY ) , a clinical-stage company specializing in immunotherapy for oncology, on Thursday said it will start enrollment for a new GOBLET study pancreatic cancer cohort after receiving German regulatory and ethics approvals. This cohort will evaluate Oncolytic's pelareorep in combination with modified folfirinox (mFOLFIRINOX) with or without the PD-L1...
Market Chatter: Whistleblower Claims Boeing Supplier Spirit AeroSystems Regularly Shipped Defective Fuselages
Market Chatter: Whistleblower Claims Boeing Supplier Spirit AeroSystems Regularly Shipped Defective Fuselages
May 9, 2024
08:09 AM EDT, 05/09/2024 (MT Newswires) -- Santiago Paredes, who worked for Spirit AeroSystems ( SPR ) , regularly found anywhere from 50 to 100, 200 defects on fuselages that were being shipped to Boeing ( BA ) , he told CBS News in an interview broadcast late Wednesday. (Market Chatter news is derived from conversations with market professionals globally....
Copyright 2023-2026 - www.financetom.com All Rights Reserved